Income Statement - Relay Therapeutics, Inc. (RLAY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.36 | 10.01 | 25.55 | 1.38 | 3.03 | 82.65 | 0.00 | 0.00 |
| Cost of revenue | 3.56 | 5.46 | 5.27 | 4.13 | 3.93 | 3.55 | 2.85 | 2.15 |
| Gross profit | 11.80 | 10.01 | 25.55 | 1.38 | 3.03 | 79.11 | -2.85 | -2.15 |
| Total operating expenses | 314.54 | 382.48 | 398.55 | 300.66 | 367.73 | 134.90 | 84.05 | 49.89 |
| Operating income | -302.74 | -372.47 | -373.00 | -299.28 | -364.70 | -55.80 | -84.05 | -49.89 |
| Non-operating income (net) | 26.26 | 34.76 | 31.03 | 8.77 | 0.83 | 3.38 | 8.74 | 1.10 |
| Income before tax | -276.48 | -337.71 | -341.97 | -290.51 | -363.87 | -52.41 | -75.31 | -48.79 |
| Income tax expense | -337.71 | -37.47 | -36.25 | 132.94 | -3.40 | -8.80 | 1.10 | |
| Net income | -276.48 | -337.71 | -341.97 | -290.51 | -363.87 | -52.41 | -66.50 | -48.79 |
Show Quarterly Income Statement
Income Statement - Relay Therapeutics, Inc. (RLAY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.00 | 7.00 | 0.00 | 0.68 | 7.68 | 0.00 | 0.00 | 0.00 | 10.01 | 0.00 | 25.20 | 0.12 | 0.23 | 0.25 | 0.34 | 0.37 | 0.42 | 0.57 | 0.67 | 0.84 | 0.95 | 82.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of revenue | 0.50 | 0.60 | 0.75 | 1.00 | 1.33 | 1.37 | 1.37 | 1.40 | 1.38 | 81.49 | 88.20 | 82.83 | 63.93 | 66.90 | 60.51 | 51.67 | 51.08 | 44.16 | 45.15 | 30.62 | 0.91 | 24.38 | 21.67 | 21.70 | |||||
| Gross profit | 2.50 | 6.40 | -0.75 | 0.68 | 7.68 | -7.24 | -1.37 | -1.37 | 10.01 | 0.00 | -56.29 | -88.08 | -82.60 | -63.67 | -66.56 | -60.15 | -51.25 | -50.51 | -43.49 | -44.30 | -29.67 | 81.74 | -24.38 | -21.67 | -21.70 | ||||
| Total operating expenses | 81.09 | 67.03 | 80.39 | 77.52 | 92.55 | 84.98 | 96.37 | 100.76 | 100.37 | 92.20 | 17.29 | 17.97 | 18.58 | 9.18 | 19.34 | 17.67 | 11.47 | 17.21 | 17.50 | 149.28 | 12.74 | 46.75 | 36.61 | 27.72 | 26.46 | 25.83 | 21.91 | 19.91 | 16.40 |
| Operating income | -78.59 | -60.63 | -80.39 | -76.85 | -84.87 | -84.98 | -96.37 | -100.76 | -90.36 | -92.20 | -73.58 | -106.05 | -101.18 | -72.85 | -85.89 | -77.81 | -62.72 | -67.72 | -60.99 | -193.58 | -42.41 | 34.99 | -36.61 | -27.72 | -26.46 | -25.83 | -21.91 | -19.91 | -16.40 |
| Non-operating income (net) | 5.30 | 5.74 | 6.24 | 6.47 | 7.80 | 8.98 | 8.26 | 8.55 | 8.98 | 8.70 | 7.84 | 7.55 | 6.94 | 5.35 | 1.72 | 1.02 | 0.68 | 0.27 | 0.16 | 0.18 | 0.22 | 0.29 | 0.53 | 1.00 | 1.57 | 1.92 | 2.24 | 2.37 | 2.22 |
| Income before tax | -73.29 | -54.89 | -74.15 | -70.38 | -77.07 | -76.00 | -88.11 | -92.21 | -81.39 | -83.50 | -65.73 | -98.51 | -94.24 | -67.50 | -84.17 | -76.79 | -62.05 | -67.46 | -60.83 | -193.40 | -42.18 | 35.28 | -36.08 | -26.72 | -24.89 | -23.91 | -19.67 | -17.54 | -14.18 |
| Income tax expense | 1.35 | 18.01 | -1.36 | -9.71 | -6.94 | -24.19 | 3.09 | -0.81 | -10.56 | -0.84 | 0.16 | 0.18 | 0.22 | 0.29 | 0.53 | 1.00 | 1.57 | 1.92 | 2.24 | 2.37 | 2.22 | ||||||||
| Net income | -73.29 | -54.89 | -74.15 | -70.38 | -77.07 | -76.00 | -88.11 | -92.21 | -81.39 | -83.50 | -65.73 | -98.51 | -94.24 | -67.50 | -84.17 | -76.79 | -62.05 | -67.46 | -60.83 | -193.40 | -42.18 | 35.28 | -36.08 | -26.72 | -24.89 | -23.91 | -19.67 | -17.54 | -14.18 |